Overview


H.R.2375: Preserve Access to Affordable Generics and Biosimilars Act


    About the Bill
  • To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market. read more
  • Sponsor and Status
  • Cosponsors
    History
  • Introduced 29 April, 2019
  • Passed House Pending
  • Passed Senate Pending
  • Signed by President No Veto
  • Enacted Pending
  • Users Votes Chart
    No user votes have been made on this bill yet.
    Representatives Votes Chart
    No house representatives votes have been made on this bill yet.
    No senate representatives votes have been made on this bill yet.